Back to MORGAN STANLEY MORGAN STANLEY

QNRXQNRX
5 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in QUOIN PHARMACEUTICALS LTD

Yes. Morgan Stanley holds 8,000 shares of QNRX (Quoin Pharmaceuticals), worth $38,720, as of its Q2 2026 13F filing. It increased the position by 4,000 shares (+100.0%) from Q1 2026. Morgan Stanley has held QNRX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$38,720

Current Shares

8,000

Total Value Change

+$36,819

Total Shares Change

+7,794

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8,000
+100.0%
$38,7200.0%$4.84
22
2026-Q1
Increased
4,000
+33.3%
$26,4000.0%$6.60
17
2025-Q4
New
3,000
-
$43,2900.0%$14.43
31
2025-Q3
Exited
0
-100.0%
$00.0%$7.19
0
2025-Q2
New
206
-
$1,9010.0%$9.23
17

Other major holders of QNRX: Woodline Partners LP, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used